Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
PAION
PAION
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Byfavo
Remimazolam
2021-03-26
2027-2033
Conscious sedation
Xerava
Eravacycline
2018-09-20
2029-2037
Infections
,
Bacterial infections
,
Intraabdominal infections
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Remimazolam
biological availability
,
healthy volunteers/patients
,
substance-related disorders
,
general anesthesia
,
endoscopy
,
covid-19
,
sepsis
,
stroke
,
respiratory insufficiency
,
shock
,
wounds and injuries
,
anesthesia
,
colonoscopy
,
intravenous anesthesia
,
bronchoscopy
Angiotensin ii
chronic renal insufficiency
,
hypertension
,
kidney diseases
,
albuminuria
Benzodiazepine
epilepsy
Benzocaine
colonoscopy
Desmoteplase
ischemia
,
cerebral infarction
,
stroke
,
ischemic stroke
Bevifimod
hemolytic-uremic syndrome
ENECADIN
ischemic stroke
,
stroke
Lotamilast
chronic obstructive pulmonary disease
,
sleep wake disorders
,
alcoholism
,
addictive behavior
,
huntington disease
,
healthy volunteers/patients
,
neoplasms
,
hypoxia
,
anxiety disorders
,
major depressive disorder
,
depressive disorder
,
pain
,
gastroparesis
,
type 2 diabetes mellitus
,
sleep initiation and maintenance disorders
,
obesity
,
dyslipidemias
,
cholestasis
,
pruritus
,
biliary liver cirrhosis
,
diabetes mellitus
,
critical illness
,
intrahepatic cholestasis
,
subarachnoid hemorrhage
,
intracranial vasospasm
,
body weight
,
back pain
,
hypercholesterolemia
,
inflammation
Nadide
respiratory syncytial viruses
,
human influenza
,
covid-19
Nepidermin
head and neck neoplasms
,
squamous cell carcinoma of head and neck
,
non-small-cell lung carcinoma
,
squamous cell carcinoma
,
squamous cell neoplasms
,
colorectal neoplasms
,
lung neoplasms
,
carcinoma
,
breast neoplasms
,
ovarian neoplasms
,
triple negative breast neoplasms
,
endometrial neoplasms
,
uterine neoplasms
,
fallopian tube neoplasms
,
adenocarcinoma
,
mesothelioma
Remetinostat
amyotrophic lateral sclerosis
,
motor neuron disease
,
sclerosis
,
prostatic neoplasms
,
castration-resistant prostatic neoplasms
,
parkinson disease
,
respiratory tract infections
,
infections
,
communicable diseases
,
drug-related side effects and adverse reactions
,
kidney transplantation
Usistapide
healthy volunteers/patients
,
obstructive lung diseases
,
low back pain
,
back pain
,
migraine disorders
,
schizophrenia
,
pharmacokinetics
,
pharmacological phenomena
,
chronic obstructive pulmonary disease
,
respiration disorders
,
bronchiolitis obliterans syndrome
,
cystic fibrosis
,
breast neoplasms
,
type 2 diabetes mellitus
,
insulin resistance
,
pain
,
bronchiectasis
,
major depressive disorder
,
fibrosis
,
social phobia
Therasphere
carcinoma
,
hepatocellular carcinoma
,
liver neoplasms
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use